$0.42
3.67%
Nasdaq, Jul 03, 10:12 pm CET
ISIN
US74345W1080
Symbol
PRPH

ProPhase Labs, Inc. Stock price

$0.42
+0.04 9.90% 1M
-0.41 49.68% 6M
-0.34 44.72% YTD
-3.21 88.47% 1Y
-12.50 96.76% 3Y
-0.81 65.93% 5Y
-0.37 46.78% 10Y
-4.53 91.55% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
+0.01 3.67%
ISIN
US74345W1080
Symbol
PRPH

Key metrics

Basic
Market capitalization
$17.4m
Enterprise Value
$26.2m
Net debt
$8.8m
Cash
$90.0k
Shares outstanding
41.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.5 | 0.8
EV/Sales
3.7 | 1.2
EV/FCF
negative
P/B
1.2
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | -22.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$7.1m | $21.8m
EBITDA
$-12.9m | $19.3m
EBIT
$-19.4m | $-10.5m
Net Income
$-8.8m | $-23.7m
Free Cash Flow
$-15.8m
Growth (TTM | estimate)
Revenue
-75.5% | 221.8%
EBITDA
46.6% | 160.4%
EBIT
36.9%
Net Income
62.8% | 55.5%
Free Cash Flow
10.5%
Margin (TTM | estimate)
Gross
-1.6%
EBITDA
-182.5% | 88.7%
EBIT
-275.5%
Net
-124.4% | -108.9%
Free Cash Flow
-223.6%
Financial Health
Equity Ratio
11.6%
Return on Equity
-725.7%
ROCE
-74.6%
ROIC
-47.7%
Debt/Equity
0.6
More
EPS
$-0.2
FCF per Share
$-0.4
Short interest
0.4%
Employees
96
Rev per Employee
$70.0k
Show more

Is ProPhase Labs, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

ProPhase Labs, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a ProPhase Labs, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a ProPhase Labs, Inc. forecast:

Buy
86%
Hold
14%

Financial data from ProPhase Labs, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
7.05 7.05
75% 75%
100%
- Direct Costs 7.17 7.17
69% 69%
102%
-0.12 -0.12
102% 102%
-2%
- Selling and Administrative Expenses 19 19
44% 44%
269%
- Research and Development Expense 0.36 0.36
77% 77%
5%
-13 -13
47% 47%
-183%
- Depreciation and Amortization 6.56 6.56
2% 2%
93%
EBIT (Operating Income) EBIT -19 -19
37% 37%
-276%
Net Profit -8.77 -8.77
63% 63%
-124%

In millions USD.

Don't miss a Thing! We will send you all news about ProPhase Labs, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ProPhase Labs, Inc. Stock News

Neutral
GlobeNewsWire
10 days ago
UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar days (the "Extension Notice") from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement s...
Neutral
GlobeNewsWire
19 days ago
BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States
Neutral
GlobeNewsWire
about one month ago
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory Board to support the clinical adoption and commercialization of its breakthrough BE-SmartTM molecular test for esophageal disease. The advisory board wil...
More ProPhase Labs, Inc. News

Company Profile

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Head office United States
CEO Ted Karkus
Employees 96
Founded 1989
Website www.prophaselabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today